Alveo Technologies developed this groundbreaking product in partnership with x-Ovo, Royal GD and Pharmsure; first shipments of Flockscreen to EMEA expected Q3 2024 ALAMEDA, Calif., June...
Developed a ‘Niclosamide-based multi-treatment drug’ that can simultaneously treat mosquito-borne viral infections such as four serotypes of dengue virus, Zika, Chikungunya, and Yellow Fever. Accelerating preparations...